| 1 |
29051279 | Expansion of EPOR-negative macrophages besides erythroblasts by elevated EPOR signaling in erythrocytosis mouse models. | 2018 Jan |
1 |
| 2 |
22089494 | Prolonged regulatable expression of EPO from an HSV vector using the LAP2 promoter element. | 2012 Nov |
3 |
| 3 |
20924361 | Prevention of diabetic neuropathy by regulatable expression of HSV-mediated erythropoietin. | 2011 Feb |
3 |
| 4 |
20499015 | Death switch for gene therapy: application to erythropoietin transgene expression. | 2010 Jul |
1 |
| 5 |
15468192 | Inducible production of erythropoietin using intramuscular injection of block copolymer/DNA formulation. | 2005 Jan |
1 |
| 6 |
12161181 | Long-term doxycycline-regulated secretion of erythropoietin by encapsulated myoblasts. | 2002 Aug |
3 |
| 7 |
12498775 | Mechanisms leading to sustained reversion of beta-thalassemia in mice by doxycycline-controlled Epo delivery from muscles. | 2002 Dec |
1 |
| 8 |
10048390 | Control of erythropoietin secretion by doxycycline or mifepristone in mice bearing polymer-encapsulated engineered cells. | 1999 Feb 10 |
5 |
| 9 |
9716577 | Control of erythropoietin delivery by doxycycline in mice after intramuscular injection of adeno-associated vector. | 1998 Sep 1 |
4 |
| 10 |
9055857 | Long-term control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblasts. | 1997 Mar |
2 |